Home>>Signaling Pathways>> Others>>eukaryotic translation initiation factor 3

eukaryotic translation initiation factor 3 Sale

(Synonyms: H2N-Asn-Leu-Gln-Leu-Leu-Met-Asp-Arg-Val-OH ) 目录号 : GP10039

Eukaryotic translation initiator

eukaryotic translation initiation factor 3 Chemical Structure

规格 价格 库存 购买数量
1mg
¥378.00
现货
5mg
¥1,103.00
现货
10mg
¥1,911.00
现货
25mg
¥2,436.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

Eukaryotic initiation factors (eIF) are proteins involved in the initiation phase of eukaryotic translation. eIF3 binds to the ribosome subunit-mRNA complex. It has been implicated in preventing the large ribosomal subunit from binding the small subunit before it is ready to commence elongation. In mammals, eIF3 is the largest scaffolding initiation factor, made up of 13 subunits (a-m). It is roughly ~750 kDa and it controls the assembly of40S ribosomal subunit on mRNA that have a 5' cap or an IRES (Internal Ribosomal Entry Site). eIF3 uses the eIF4F complex or IRES from viruses to position the mRNA strand near the exit site of the 40S ribosome subunit, thus promoting the assembly of the pre-initiation complex.[1]

PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. [2]. Amplification of EIF3S3 gene is common in late-stage prostate cancersuggesting that it may be functionally involved in the progression of the disease [3]. Recent study shows that eukaryotic translation initiation factor 3 subunit 3 does not seem to be overrepresentedindependent of c-myc in prostate cancer [4].

References:
1. Umadas Maitra, Jayanta Chaudhuri; Jayanta Chaudhuri, Kausik Si (21). "Function of Eukaryotic Translation Initiation Factor 1A (eIF1A) (Formerly Called eIF-4C) in Initiation of Protein Synthesis". The Journal of BIological Chemistry 272 (12): 7883-7891. doi:10.1074/jbc.272.12.7883. Retrieved 19 February 2012.
2. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Okamoto, H., Yasui, K., Zhao, C., Arii, S., Inazawa, J. Hepatology (2003)
3. Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. Saram?ki, O., Willi, N., Bratt, O., Gasser, T.C., Koivisto, P., Nupponen, N.N., Bubendorf, L., Visakorpi, T. Am. J. Pathol. (2001)
4. Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer. Tsuchiya, N., Kondo, Y., Takahashi, A., Pawar, H., Qian, J., Sato, K., Lieber, M.M., Jenkins, R.B. Am. J. Pathol. (2002)

Chemical Properties

Cas No. SDF
别名 H2N-Asn-Leu-Gln-Leu-Leu-Met-Asp-Arg-Val-OH
Canonical SMILES NC(CC(N)=O)C(NC(CC(C)C)C(NC(CCC(N)=O)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(CCSC)C(NC(CC(O)=O)C(NC(CCCNC(N)=N)C(NC(C(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O
分子式 C47H84N14O14S 分子量 1101.32
溶解度 ≥ 110.1mg/mL in DMSO 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 0.908 mL 4.54 mL 9.08 mL
5 mM 0.1816 mL 0.908 mL 1.816 mL
10 mM 0.0908 mL 0.454 mL 0.908 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置